Workflow
【私募调研记录】正圆投资调研维力医疗、晶科能源等3只个股(附名单)
Zheng Quan Zhi Xing·2025-08-01 00:06

Group 1: Weili Medical - Weili Medical reported that its overseas production costs are slightly higher than domestic ones, but savings on shipping and storage are expected to keep gross margins stable [1] - The gross margin for urology products exceeds 70%, driven by domestic brand effects, import substitution, and overseas market expansion [1] - The company has increased its efforts to export urology products since 2023, resulting in significant growth in external sales revenue over the past two years [1] - Production capacity is concentrated in five cities, with new factories being built in Indonesia and Mexico to mitigate geopolitical risks and enhance automation levels [1] Group 2: JinkoSolar - JinkoSolar emphasized the need to control new capacity in the photovoltaic industry to address intense competition and guide prices back to rational levels [2] - The company is making progress in upgrading high-power products, with partial deliveries of products over 640W expected in Q3, and a majority of orders transitioning to these products next year [2] - JinkoSolar anticipates that its TOPCon capacity will reach 670W next year, with potential for 680-700W in the next 2-3 years, and aims to improve battery mass production efficiency to over 28% [2] - The global photovoltaic market demand remains stable, with a return to normal demand in China and rapid growth in emerging overseas markets, leading to stable component prices [2] Group 3: Yahua Group - Yahua Group is a leading producer of lithium salt products, particularly battery-grade lithium hydroxide, with industry-leading production technology and stable product quality [3] - The company serves major global automotive and battery manufacturers, with top clients like Tesla, LGES, and CATL accounting for 90% of revenue [3] - Yahua has established a diversified supply chain for lithium ore, including self-controlled mines in Zimbabwe and Sichuan, as well as long-term purchase agreements for external sources [3] - The company’s civil explosives business covers over 20 provinces in China and extends to countries like Australia, New Zealand, and Zimbabwe [3] - In 2024, Yahua plans to hedge against price fluctuations in lithium salt products through futures contracts for lithium carbonate [3] Group 4: Institutional Overview - Shenzhen Zhengyuan Investment was established in 2015 in the Qianhai Free Trade Zone and obtained a private securities investment fund license in the same year [4] - The firm has a professional research team, rich investment experience, and a comprehensive risk management system [4] - Zhengyuan focuses on the transformation and upgrading of the Chinese economy, aiming to connect social capital with quality industries to achieve asset preservation and appreciation for clients [4]